Metabolic changes and DNA hypomethylation in cerebellum are associated with behavioral alterations in mice exposed to trichloroethylene postnatally

Toxicology and Applied Pharmacology

Volumn 269, Issue 3, 2013, Pages 263-269

  Blossom, Sarah J ^a   Cooney, Craig A ^b   Melnyk, Stepan B ^a   Rau, Jenny L ^a   Swearingen, Christopher J ^a   Wessinger, William D ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Cerebellum; Locomotor behavior; Methylation; Oxidative stress; Trichloroethylene

Indexed keywords

CYSTEINYLGLYCINE; DRINKING WATER; GLUTATHIONE; REACTIVE NITROGEN SPECIES; TRICHLOROETHYLENE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN METABOLISM; CEREBELLUM; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; MOUSE; NERVE CELL PLASTICITY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; CEREBELLUM; CYSTEINE; DNA METHYLATION; GLUTATHIONE; MALE; MICE; MICE, INBRED MRL LPR; OXIDATION-REDUCTION; OXIDATIVE STRESS; TRICHLOROETHYLENE; TYROSINE;

MUS;

EID: 84876976466     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.03.025     Document Type: Article

References (55)

1. Adgate J.L., Eberly L.E., Stroebel C., Pellizzari E.D., Sexton K. Personal, indoor, and outdoor VOC exposures in a probability sample of children. J. Expo. Anal. Environ. Epidemiol. 2004, 14(Suppl. 1):S4-S13.
2. Andreazza A.C., Kapczinski F., Kauer-Sant'Anna M., Walz J.C., Bond D.J., Goncalves C.A., Young L.T., Yatham L.N. 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J. Psychiatry Neurosci. 2009, 34:263-271.
3. Bale A.S., Barone S., Scott C.S., Cooper G.S. A review of potential neurotoxic mechanisms among three chlorinated organic solvents. Toxicol. Appl. Pharmacol. 2011, 255:113-126.
4. Ballok D.A. Neuroimmunopathology in a murine model of neuropsychiatric lupus. Brain Res. Rev. 2007, 54:67-79.
5. Ballok D.A., Earls A.M., Krasnik C., Hoffman S.A., Sakic B. Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice. J. Neuroimmunol. 2004, 152:83-97.
6. Balu D.T., Hodes G.E., Anderson B.T., Lucki I. Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments. Neuropsychopharmacology 2009, 34:1764-1773.
7. Beamer P.I., Luik C.E., Abrell L., Campos S., Martinez M.E., Saez A.E. Correction to concentration of trichloroethylene in breast milk and household water from Nogales, Arizona. Environ. Sci. Technol. 2012, 46:11483.
8. Belzung C., Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav. Brain Res. 2001, 125:141-149.
9. Biswas S., Chida A.S., Rahman I. Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem. Pharmacol. 2006, 71:551-564.
10. Blossom S.J., Doss J.C. Trichloroethylene alters central and peripheral immune function in autoimmune-prone MRL(+/+) mice following continuous developmental and early life exposure. J. Immunotoxicol. 2007, 4:129-141.
11. Blossom S.J., Doss J.C., Gilbert K.M. Ability of trichloroethylene metabolite to promote immune pathology is strain-specific. J. Immunotoxicol. 2006, 3:179-187.
12. Blossom S.J., Doss J.C., Hennings L.J., Jernigan S., Melnyk S., James S.J. Developmental exposure to trichloroethylene promotes CD4(+) T cell differentiation and hyperactivity in association with oxidative stress and neurobehavioral deficits in MRL+/+ mice. Toxicol. Appl. Pharmacol. 2008, 231:344-353.
13. Blossom S.J., Melnyk S., Cooney C.A., Gilbert K.M., James S.J. Postnatal exposure to trichloroethylene alters glutathione redox homeostasis, methylation potential, and neurotrophin expression in the mouse hippocampus. Neurotoxicology 2012, 33:1518-1527.
14. Butterfield D.A., Sultana R. Identification of 3-nitrotyrosine-modified brain proteins by redox proteomics. Methods Enzymol. 2008, 440:295-308.
15. Butterfield D.A., Perluigi M., Sultana R. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur. J. Pharmacol. 2006, 545:39-50.
16. Cabanlit M., Wills S., Goines P., Ashwood P., Van de W.J. Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann. N. Y. Acad. Sci. 2007, 1107:92-103.
17. Castro R., Rivera I., Struys E.A., Jansen E.E., Ravasco P., Camilo M.E., Blom H.J., Jakobs C., Tavares de Almeida I. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin. Chem. 2003, 1292-1296.
18. Caudill M.A., Wang J.C., Melnyk S., Pogribny I.P., Jernigan S., Collins M.D., Santos-Guzman J., Swendseid M.E., Cogger E.A., James S.J. Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. J. Nutr. 2001, 131:2811-2818.
19. Chiu W.A., Caldwell J.C., Keshava N., Scott C.S. Key scientific issues in the health risk assessment of trichloroethylene. Environ. Health Perspect. 2006, 114:1445-1449.
20. Comi A.M., Zimmerman A.W., Frye V.H., Law P.A., Peeden J.N. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J. Child Neurol. 1999, 14:388-394.
21. Crawley J.N. Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol. 2007, 17:448-459.
22. Feil R. Environmental and nutritional effects on the epigenetic regulation of genes. Mutat. Res. 2006, 600:46-57.
23. Fernandez-Fernandez S., Almeida A., Bolanos J.P. Antioxidant and bioenergetic coupling between neurons and astrocytes. Biochem. J. 2012, 443:3-11.
24. Gilbert K.M., Nelson A.R., Cooney C.A., Reisfeld B., Blossom S.J. Epigenetic alterations may regulate temporary reversal of CD4+ T cell activation caused by trichloroethylene exposure. Toxicol. Sci. 2012, 127(1):169-178. (May).
25. Heindel J.J. Animal models for probing the developmental basis of disease and dysfunction paradigm. Basic Clin. Pharmacol. Toxicol. 2008, 102:76-81.
26. Hodes G.E., Hill-Smith T.E., Lucki I. Fluoxetine treatment induces dose dependent alterations in depression associated behavior and neural plasticity in female mice. Neurosci. Lett. 2010, 484:12-16.
27. Jain A., Martensson J., Stole E., Auld P.A., Meister A. Glutathione deficiency leads to mitochondrial damage in brain. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:1913-1917.
28. Jones H.E., Kunko P.M., Robinson S.E., Balster R.L. Developmental consequences of intermittent and continuous prenatal exposure to 1,1,1-trichloroethane in mice. Pharmacol. Biochem. Behav. 1996, 55:635-646.
29. Kilburn K.H., Warshaw R.H. Effects on neurobehavioral performance of chronic exposure to chemically contaminated well water. Toxicol. Ind. Health 1993, 9:391-404.
30. Laslo-Baker D., Barrera M., Knittel-Keren D., Kozer E., Wolpin J., Khattak S., Hackman R., Rovet J., Koren G. Child neurodevelopmental outcome and maternal occupational exposure to solvents. Arch. Pediatr. Adolesc. Med. 2004, 158:956-961.
31. Maffi S.K., Rathinam M.L., Cherian P.P., Pate W., Hamby-Mason R., Schenker S., Henderson G.I. Glutathione content as a potential mediator of the vulnerability of cultured fetal cortical neurons to ethanol-induced apoptosis. J. Neurosci. Res. 2008, 86:1064-1076.
32. McLean C.W., Mirochnitchenko O., Claus C.P., Noble-Haeusslein L.J., Ferriero D.M. Overexpression of glutathione peroxidase protects immature murine neurons from oxidative stress. Dev. Neurosci. 2005, 27:169-175.
33. Melnyk S., Pogribna M., Pogribny I., Hine R.J., James S.J. A new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulometric electrochemical detection. J. Nutr. Biochem. 1999, 10:490-497.
34. Melnyk S., Fuchs G.J., Schulz E., Lopez M., Kahler S.G., Fussell J.J., Bellando J., Pavliv O., Rose S., Seidel L., Gaylor D.W., Jill J.S. Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism. J. Autism Dev. Disord. 2012, 42(3):367-377. (Mar).
35. Molloy C.A., Morrow A.L., Meinzen-Derr J., Schleifer K., Dienger K., Manning-Court, Altaye M., Wills-Karp M. Elevated cytokine levels in children with autism spectrum disorder. J. Neuroimmunol. 2006, 172:198-205.
36. Mosharov E., Cranford M.R., Banerjee R. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 2000, 39:13005-13011.
37. Mythri R.B., Harish G., Dubey S.K., Misra K., Bharath M.M. Glutamoyl diester of the dietary polyphenol curcumin offers improved protection against peroxynitrite-mediated nitrosative stress and damage of brain mitochondria in vitro: implications for Parkinson's disease. Mol. Cell. Biochem. 2011, 347:135-143.
38. Nakazawa H., Fukuyama N., Takizawa S., Tsuji C., Yoshitake M., Ishida H. Nitrotyrosine formation and its role in various pathological conditions. Free Radic. Res. 2000, 33:771-784.
39. Noble M., Mayer-Proschel M., Proschel C. Redox regulation of precursor cell function: insights and paradoxes. Antioxid. Redox Signal. 2005, 7:1456-1467.
40. Onishchenko N., Karpova N., Sabri F., Castren E., Ceccatelli S. Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury. J. Neurochem. 2008, 106:1378-1387.
41. Rasmussen K., Arlien-Soborg P., Sabroe S. Clinical neurological findings among metal degreasers exposed to chlorinated solvents. Acta Neurol. Scand. 1993, 87:200-204.
42. Reif J.S., Burch J.B., Nuckols J.R., Metzger L., Ellington D., Anger W.K. Neurobehavioral effects of exposure to trichloroethylene through a municipal water supply. Environ. Res. 2003, 93:248-258.
43. Roth T.L., Zoladz P.R., Sweatt J.D., Diamond D.M. Epigenetic modification of hippocampal Bdnf DNA in adult rats in an animal model of post-traumatic stress disorder. J. Psychiatr. Res. 2011, 45:919-926.
44. Sajdel-Sulkowska E.M., Xu M., McGinnis W., Koibuchi N. Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD). Cerebellum 2011, 10:43-48.
45. Sakic B., Hanna S.E., Millward J.M. Behavioral heterogeneity in an animal model of neuropsychiatric lupus. Biol. Psychiatry 2005, 57:679-687.
46. Sato H., Takahashi T., Sumitani K., Takatsu H., Urano S. Glucocorticoid generates ROS to induce oxidative injury in the hippocampus, leading to impairment of cognitive function of rats. J. Clin. Biochem. Nutr. 2010, 47:224-232.
47. Selhub J. Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J. Nutr. Health Aging 2002, 6:39-42.
48. Sexton K., Adgate J.L., Church T.R., Ashley D.L., Needham L.L., Ramachandran G., Fredrickson A.L., Ryan A.D. Children's exposure to volatile organic compounds as determined by longitudinal measurements in blood. Environ. Health Perspect. 2005, 113:342-349.
49. Shanker G., Aschner M. Identification and characterization of uptake systems for cystine and cysteine in cultured astrocytes and neurons: evidence for methylmercury-targeted disruption of astrocyte transport. J. Neurosci. Res. 2001, 66:998-1002.
50. Shanker G., Allen J.W., Mutkus L.A., Aschner M. Methylmercury inhibits cysteine uptake in cultured primary astrocytes, but not in neurons. Brain Res. 2001, 914:159-165.
51. Stringari J., Meotti F.C., Souza D.O., Santos A.R., Farina M. Postnatal methylmercury exposure induces hyperlocomotor activity and cerebellar oxidative stress in mice: dependence on the neurodevelopmental period. Neurochem. Res. 2006, 31:563-569.
52. Sweeten T.L., Bowyer S.L., Posey D.J., Halberstadt G.M., McDougle C.J. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 2003, 112:e420.
53. Till C., Koren G., Rovet J.F. Prenatal exposure to organic solvents and child neurobehavioral performance. Neurotoxicol. Teratol. 2001, 23:235-245.
54. Vitvitsky V., Thomas M., Ghorpade A., Gendelman H.E., Banerjee R. A functional transsulfuration pathway in the brain links to glutathione homeostasis. J. Biol. Chem. 2006, 281:35785-35793.
55. Yi P., Melnyk S., Pogribna M., Pogribny I.P., Hine R.J., James S.J. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J. Biol. Chem. 2000, 275:29318-29323.